Sumitovant Biopharma is a patient-first, technology-driven biopharmaceutical company that’s accelerating the development and commercialization of novel therapies for patients with rare conditions and other serious diseases. Through the company’s proprietary computing and data platforms, scientific expertise, and diverse portfolio, Sumitovant has supported development of multiple FDA-approved products and a robust pipeline of early- through late-stage investigational assets addressing unmet need in pediatrics, urology, oncology, women’s health, specialty respiratory and infectious diseases. Sumitovant is a wholly owned subsidiary of Sumitomo Pharma. (Sumitovant has combined with Sumitomo Pharma’s other U.S. subsidiaries and is now Sumitomo Pharma America.)
The company has embraced digital transformation to achieve its goals of getting research-supported drugs to market faster and improving patient lives. Sumitovant’s IT team had a vision to enable the company’s researchers, data scientists, and sales and manufacturing teams to be as nimble as possible. While building out the company’s network infrastructure from the ground up, the IT team sought a partner to help bring its vision to fruition.
“One of our biggest goals is innovation,” says Trevor Cardwell, Senior Cloud and Network Architect at Sumitovant. “We want to come up with creative ways for people to be efficient and innovate without exposing ourselves to risk, which is not always easy.”